OVERALL SURVIVAL (OS) IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS' SEQUENTIALLY TREATED WITH TARGETED THERAPIES (TTS)

被引：0
|
作者：
Procopio, G. [1 ]
Verzoni, E. [1 ]
Testa, I. [1 ]
de Braud, F. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [1] OVERALL SURVIVAL (OS) IN METASTATIC RENAL CELL CARCINOMA (MRCC) SEQUENTIALLY TREATED WITH DIFFERENT TARGETED THERAPIES (TTS): RESULTS FROM A LARGE COHORT OF PATIENTS
    Procopio, G.
    Verzoni, E.
    Testa, I.
    Iacovelli, R.
    Garanzini, E.
    De Braud, F. G. M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 272 - 273
  • [2] Overall survival (OS) in metastatic renal cell carcinoma (mRCC) sequentially treated with different targeted therapies (TTs): Results from a large cohort of patients
    Procopio, Giuseppe
    Verzoni, Elena
    Iacovelli, Roberto
    Testa, Isabella
    Salvioni, Roberto
    Nicolai, Nicola
    Porcu, Luca
    De Braud, Filippo G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] PROGRESSION FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS RECEIVING 3 TARGETED THERAPIES (TTS) FOR METASTATIC RENAL-CELL CARCINOMA (MRCC)
    Iacovelli, R.
    Santoni, M.
    Di Lorenzo, G.
    Cerbone, L.
    Aglietta, M.
    Masini, C.
    Giganti, M. O.
    Messina, C.
    Sternberg, C. N.
    Procopio, G.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 270 - 271
  • [4] Progression-free survival (PFS) and overall survival (OS) in patients receiving three targeted therapies (TTs) for metastatic renal cell carcinoma (mRCC)
    Verzoni, Elena
    Iacovelli, Roberto
    Rizzo, Mimma
    Felici, Alessandra
    Cascinu, Stefano
    Di Lorenzo, Giuseppe
    Cerbone, Linda
    Ortega, Cinzia
    Masini, Cristina
    Giganti, Maria Olga
    Lorusso, Vito
    Messina, Caterina
    Atzori, Francesco
    De Vincenzo, Fabio
    Sacco, Cosimo
    Boccardo, Francesco
    Valduga, Francesco
    Massari, Francesco
    Tassi, Renato
    Procopio, Giuseppe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [5] Progression free survival (PFS) and overall survival (OS) in patients receiving 3 targeted therapies (TTs) for metastatic renal-cell carcinoma (mRCC)
    Elena, V.
    Iacovelli, R.
    Santoni, M.
    Di Lorenzo, G.
    Cerbone, L.
    Ortega, C.
    Masini, C.
    Giganti, M. O.
    Messina, C.
    De Vincenzo, F.
    Procopio, G.
    [J]. BJU INTERNATIONAL, 2012, 110 : 5 - 5
  • [6] Time from nephrectomy (Nx) as an independent prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with targeted therapies (TTs)
    Procopio, Giuseppe
    Iacovelli, Roberto
    Verzoni, Elena
    Grassi, Paolo
    Testa, Isabella
    Garanzini, Enrico
    Nicolai, Nicola
    De Braud, Filippo G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [7] Targeted therapies (TTs) in metastatic renal cell carcinoma (MRCC): Role of metastatic site as a prognostic and predictive factor
    Procopio, G.
    Grassi, P.
    Porcu, L.
    Verzoni, E.
    Testa, I.
    Garanzini, E.
    Biondani, P.
    Pusceddu, S.
    De Braud, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S666 - S666
  • [8] Association between biopsychosocial distress (BPSD) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
    Bergerot, C. D.
    Clark, K. L.
    Ashing, K. T.
    Almeida, L.
    Bergerot, P. G.
    Obenchain, R.
    Dizman, N.
    Hsu, J.
    Maia, M. C.
    Philip, E.
    Loscalzo, M.
    Pal, S. K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [9] Use of progression-free survival (PFS) to predict overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
    Halabi, S.
    Rini, B. I.
    Stadler, W. M.
    Small, E. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Prognostic factors for survival in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic therapies: Overall results of a large experience.
    Procopio, G.
    Verzoni, E.
    Iacovelli, R.
    Mattana, F.
    Guadalupi, V.
    Mariani, L.
    Stagni, S.
    Salvioni, R.
    Buzzoni, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345